Recently Handled Cases E-mail
 
 

Kyros & Pressly LLP has a proven track record in fighting for shareholder rights in merger and acquisition deal cases. Below you will find some recent merger and acquisition actions that have been handled by Kyros & Pressly, LLP on behalf of shareholders.

  • Solutia Systems (SOA) -  Representation of shareholder interests in $3.38 billion dollar Eastman Chemical purchase of Solutia, a St Louis based company that makes specialty chemicals used in the automotive and architectural industries.
  • Pacific Capital Bancorp (PCBR) -  $1.51 Billion dollar bank buyout, representation of stock holders in purchase by Japanese based UnionBanCal.
  • New Frontier Communications (NOOF) - Representation of shareholders in proposed $20 million dollar buyout of pay per view company by Longkloof.
  • Merisel - Shareholder represented in Delaware courts in offer that would take National Graphic Design company private.
  • Novellus Systems - Representation of shareholder in $3.3 billion dollar semiconductor company deal. Case filed in California.
  • Openlane (OPNN) - Being acquired by KAR Auction Services Inc for $210 million, the companies operate wholesale online auto auction services. Lawsuit filed to get adequate proxy and disclosures from the Open Lane.
  • China ACM - Unfair Buyout Offer. Representation of shareholder with over 500,000 shares. Lawsuit Filed alleging too low share price offer.
  • Motorola Mobility (MMI) - Google offer to Takeover Motorola for 12 Billion. Lawsuit filed, many questions by Motorola shareholders.
  • PAETEC Holding Corp - Offer to buyout Paetec shareholders for $891 Million by Windstream. Lawsuit filed on behalf of small investor.
  • Medco Health Solutions - one of the largest transactions of 2011 a 29 Billion dollar deal involving a pharmacy services company that serves 65 million people, acquired by Express Scripts Inc. Lawsuit filed in Delaware.
  • Petrohawk Energy - a 12 Billion dollar buyout of an oil exploration company by a Large oil company. Lawsuit filed in Delaware.
  • Icagen - a $56 million dollar buyout of a bio-drug company by Pfizer. Lawsuit brought in Delaware.